Title

Delay in OnabotulinumtoxinA Treatment During the COVID-19 Pandemic-Perspectives from a Virus Hotspot

Document Type

Article

Publication Date

6-1-2020

Publication Title

Headache

Abstract

The COVID-19 pandemic has undoubtedly changed our practice of medicine. With our collective resources and attention focused on caring for those afflicted with the disease, other medical conditions have temporarily but understandably faced constraint. For migraine patients who often require in-person visits for infusions and procedures, this has become particularly challenging. Here, we share our experience in navigating this exigency amidst a local surge of COVID-19.

Medical Subject Headings

Adult; Betacoronavirus; Botulinum Toxins, Type A; Coronavirus Infections; Female; Humans; Middle Aged; Migraine Disorders; Pandemics; Pneumonia, Viral; Time-to-Treatment; Treatment Outcome

PubMed ID

32359098

Volume

60

Issue

6

First Page

1183

Last Page

1186

Share

COinS